HSP90AA1 and neoplasm: Interestingly, loss of wtAR protein was not observed by HSP90 inhibition in VCaP cells, a response that is incongruent with other prostate cancer cell lines (e.g. LNCaP, C4-2B, 22Rv1) and tumor explants [26, 27, 34, 35].